During the past decade, Municipal Institute for Lung Diseases and Tuberculosis conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Municipal Institute for Lung Diseases and Tuberculosis" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Municipal Institute for Lung Diseases and Tuberculosis" are "Pulmonary Arterial Hypertension" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Municipal Institute for Lung Diseases and Tuberculosis" in a lesser frequency.

Most popular intervention types in "Municipal Institute for Lung Diseases and Tuberculosis" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Macitentan" (1 trials), "Pamrevlumab" (1 trials), "Placebo" (1 trials), "macitentan (ACT-064992)" (1 trials) and "placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Municipal Institute for Lung Diseases and Tuberculosis" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Municipal Institute for Lung Diseases and Tuberculosis". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Municipal Institute for Lung Diseases and Tuberculosis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Municipal Institute for Lung Diseases and Tuberculosis, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".